Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07563270

GAPcareAD: A Brief Emergency Department Intervention to Address Post-Fall Care Needs of Persons Living With Dementia and Care Partners

Persons living with dementia (PLWD) are at significantly increased risk for falls, which are the leading cause of emergency department (ED) visits in this population and contribute to serious injuries, functional decline, and caregiver burden. GAPcareAD is an ED-initiated, caregiver-inclusive intervention designed to address fall risk at the point of care. This multi-site trial will compare GAPcareAD (intervention) to usual care for 350 PLWD and caregivers after a fall.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

This multi-site randomized controlled trial will evaluate the efficacy of GAPcareAD compared to usual care among 350 PLWD and their caregivers (dyads) presenting to one of the three EDs after a fall. The intervention includes pharmacist- and physical therapist-led assessments, targeted modification of fall risk factors, and coordinated communication of fall prevention plans with caregivers and care teams. Outcomes include fall-related ED visits, injuries, hospitalizations, quality of life, caregiver burden, and adherence to recommendations over 6 months. GAPcareAD aims to determine whether a pragmatic, ED-based intervention can reduce fall-related healthcare utilization and improve patient and caregiver outcomes, while informing future large-scale implementation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Community-dwelling adult (living at home or assisted living) 65 years-old or older presenting to ED after a fall within the last seven days
  • Fall not due to syncope or external force (i.e., struck by car,assault, intoxication)
  • Fall not due to serious illness (i.e., stroke, acute myocardial infarction)
  • Patients have an identified caregiver
  • Patient must have known ADRD or score ≥2 on the AD8 Dementia Interview.
  • Anticipated to be discharged to home/assisted living/rehabilitation at the time of consent (i.e. not admitted)
  • The patient and/or caregiver have a reliable phone number where they can be reached throughout the intervention

Exclusion criteria

  • Living in a nursing home
  • Patients are admitted to the hospital
  • Patients who have advanced cancer and/or are in hospice
  • Patients have presence of injuries that prevent mobilization (i.e. pelvic or lower extremity fractures)

Treatment and study plan

Fall Prevention

Other

GAPcareAD - Pharmacists perform medication review and recommend modifying fall risk increasing medication. PTs perform fall risk assessments and tailor recommendations based on fall risk and patient's gait, balance, and mobility impairments. Through purposeful engagement by staff, caregivers are encouraged to contribute to the action plans.

Primary outcomes

  1. Effect of intervention

    Time frame: 6 months

    The primary outcome is the number of fall-related emergency department visits per participant within 6 months after randomization, comparing participants receiving the GAPcareAD intervention verses usual care.

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Collaborators

  • National Institute on Aging (NIA)

Registry information

Acronym: GAPcareAD

Important dates

Study start
2026
Primary completion
2029
Study completion
2031
First posted
May 4, 2026
Registry last updated
May 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.